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Abstract
Background: South Africa (SA) has experienced a rapid transition in the Human Development Index (HDI) over the
past decade, which had an effect on the incidence and mortality rates of colorectal cancer (CRC). This study aims to
provide CRC incidence and mortality trends by population group and sex in SA from 2002 to 2014.
Methods: Incidence data were extracted from the South African National Cancer Registry and mortality data
obtained from Statistics South Africa (STATS SA), for the period 2002 to 2014. Age-standardised incidence rates
(ASIR) and age-standardised mortality rates (ASMR) were calculated using the STATS SA mid-year population as the
denominator and the Segi world standard population data for standardisation. A Joinpoint regression analysis was
computed for the CRC ASIR and ASMR by population group and sex.
Results: A total of 33,232 incident CRC cases and 26,836 CRC deaths were reported during the study period. Of the
CRC cases reported, 54% were males and 46% were females, and among deaths reported, 47% were males and
53% were females. Overall, there was a 2.5% annual average percentage change (AAPC) increase in ASIR from 2002
to 2014 (95% CI: 0.6–4.5, p-value < 0.001). For ASMR overall, there was 1.3% increase from 2002 to 2014 (95% CI:
0.1–2.6, p-value < 0.001). The ASIR and ASMR among population groups were stable, with the exception of the
Black population group. The ASIR increased consistently at 4.3% for black males (95% CI: 1.9–6.7, p-value < 0.001)
and 3.4% for black females (95% CI: 1.5–5.3, p-value < 0.001) from 2002 to 2014, respectively. Similarly, ASMR for
black males and females increased by 4.2% (95% CI: 2.0–6.5, p-value < 0.001) and 3.4% (, 95%CI: 2.0–4.8, p-value
< 0.01) from 2002 to 2014, respectively.
Conclusions: The disparities in the CRC incidence and mortality trends may reflect socioeconomic inequalities
across different population groups in SA. The rapid increase in CRC trends among the Black population group is
concerning and requires further investigation and increased efforts for cancer prevention, early screening and
diagnosis, as well as better access to cancer treatment.
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Background
Colorectal cancer (CRC) is regarded as a leading cause
of cancer morbidity and mortality worldwide [1]. It is
ranked third in cancer incidence and second in cancer
mortality globally [1]. In 2019, there were 1.8 million
new CRC cases and 880,792 CRC deaths worldwide [1–
3]. In 2018, the age-standardised incidence rate (ASIR)
and age-standardised mortality rate (ASMR) in the Afri-
can region were estimated at 8.2 and 5.6 per 100,000
population, respectively [4]. According to the Globocan
report, the estimated ASIR and ASMR for South Africa
(SA) in 2018 were 14.4 and 7.6 per 100,000, respectively
[5]. The latest South African National Cancer Registry
(NCR) 2016 report observed 3884 cases of CRC with an
estimated 6.81 and 11.01 ASIR per 100,000 population
for females and males, respectively [6]. There is limited
data on colorectal cancer survival in SA [7, 8]. The pa-
tient survival is dependent on multiple factors such as
the topography, morphology, staging and treatment type
[7]. According to the CONCORD-3 study for the period
from 2010 to 2014 among adults aged 15–99 years, the
5-year survival rate in SA was less than 20% [9].
Disparities in CRC between countries exist based on
the Human Development Index (HDI). HDI is a com-
posite score of life expectancy, education and per capita
income of countries [10]. Countries with a high HDI re-
ported the highest CRC incidence rates, while low HDI
countries reported the highest CRC mortality rates [1].
The CRC incidence of a country increases with increas-
ing HDI status and, as such, may be used to signal
changes in socioeconomic status [1]. The rise in inci-
dence rates in countries undergoing rapid developmental
transition may be attributed to changes in diet, obesity,
and other lifestyle factors such as higher alcohol and red
meat consumption [1, 11, 12]. On the other hand, the
increase in CRC mortality rates, observed in low HDI
countries, may be attributed to minimal or lack of ap-
propriate screening and early detection programmes,
and poor access to cancer treatment [11].
The HDI of SA has been increasing steadily since 1990
[13]. Despite an increasing HDI, the Gini coefficient in
SA is 0.63, indicating considerable societal inequality
[13, 14]. The Gini coefficient measures wealth distribu-
tion and ranges from 0 to 1, where 0 represents perfect
equality and 1 indicates perfect inequality. The inequity
in socioeconomic status and health access, among other
factors, influences the health outcomes of the SA popu-
lation [15–17]. As a result of the unique political history
of SA, many of these inequalities are apparent when
examining health trends by population groups (Black,
White, Asian, and Mixed race-commonly known as
Coloured in SA). To appropriately plan for interventions,
prevention, and control of CRC in the era of epidemio-
logic and economic transition, the evaluation of CRC
patterns across population groups, and sex are necessary.
This study aims to provide insights into the CRC inci-
dence and mortality trends by population group and sex
for SA.
Methods
Study design and data sources
A cross-sectional study was conducted using secondary
data analysis of two datasets, to determine incidence
trends and mortality trends for CRC between 2002 and
2014 in SA by sex and population groups.
To determine incident CRC trends, the NCR database
was used. The NCR methodology is outlined in detail by
Singh et al. [18]. Briefly, the NCR collects data on all
pathologically confirmed cancer cases from both public
and private laboratories across SA. The NCR then
collates, analyses, interprets and reports annual cancer
incidences by age groups, population groups, and sex.
All cancers are coded according to the International
Classification of Diseases for Oncology, 3rd edition
(ICD-O-3) [19].
The cancers reported by NCR are primary incident
cancers. Cancers reported in metastatic sites (for ex-
ample, lymph nodes) are investigated to determine the
primary tumour site and are registered with the primary
tumour site topography. If a primary site cannot be de-
termined, the tumour is registered as an unknown pri-
mary site. The CRC primary incident cases, defined as
ICD-O-3 codes C18, C19, and C20, from 2002 to 2014,
were extracted from the NCR.
The variables extracted included the year of diagnosis,
sex, population group, age at diagnosis, and morphology
and topography of cancer.
CRC deaths from 2002 to 2014 were extracted from
the Statistic South Africa (STATS SA) mortality and
causes of death database. STATS SA collates national
mortality statistics for the registered causes of deaths
from death certificates. We extracted the date of death,
sex, population group, smoking status, marital status,
education level, and age of the deceased for individuals
whose first or underlying causes of death were recorded
as CRC (ICD-O-3 codes C18, C19, and C20).
Statistical analysis
Stata® statistical software version 14.2 (StataCorp LLC,
Texas, USA) was used to generate frequencies and calcu-
late ASIR and ASMR by sex and population group. The
estimated mid-year population from STATS SA was
used as the denominator. The Segi world standard popu-
lation was used for age standardisation. The Segi world
standard population was developed by Dr. Mitsuo Segi
in the late 1950s to ensure international comparison of
rates and evaluation of changes in incidence by compar-
ing the current rates with the past published rates [20–
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22]. It was later modified in 1966 by Doll et al. [20]. It is
the most commonly used world standard population,
particularly in the field of cancer and allows in-country
and between-country comparisons [21, 23, 24]. A de-
tailed description of the calculation of the ASIR and
ASMR is available elsewhere [20]. Briefly, the crude inci-
dence rates were calculated first by dividing the total
number of new primary CRC cases/deaths observed in a
particular year by the total number of population (STAT
S SA mid-year population) in that same year, stratified
by age groups, sex and population group. The crude
rates were multiplied by the weighted Segi world stand-
ard population to obtain age-standardised incidence or
mortality rates. The weighted Segi world standard popu-
lation is calculated by dividing the Segi world standard
population for each age group (5-year intervals, e.g. 0–5
years) by the total Segi world standard population of all
age groups.
The Calculation methods are as follows:
Crude ¼ Number of new cases=deaths
Mid − year population
 100; 000
WSP weighting ¼ WSP for each age groupð Þ
Total WSP for all age groups
 100; 000
ASIR or ASMR ¼ Crude X WSP weighting
The age-standardised rates by year, sex, and popula-
tion group were imported into Joinpoint regression
statistical software for trend analysis for the study
period. The model used by Joinpoint statistical soft-
ware to create the trend patterns was described by
Kim et al. [22, 25, 26]. Joinpoint is used to identify
points (or “joinpoints”) where there is a significant
change in a trend, which enables a more nuanced
trend analysis than a standard regression method.
Furthermore, Joinpoint is used by the US National
Cancer Institute to analyse cancer trends rather than
a standard regression method [26]. All parameters
were set at default [26]. The method identifies join-
points based on regression models with zero to five
join points. The modelled or estimated annual per-
centage change was based on the trends within each
segment. To quantify for trends over a fixed number
of years the average annual percentage change
(AAPC) was calculated. The AAPC is a geometric
weighted average of the estimated average percentage
change trend analysis, with the weights the same as
the lengths of each segment during a specified fixed
interval. The AAPC was considered significant at the




A total of 33,232 incident CRC cases were reported dur-
ing the study period, 56% from private healthcare sector
laboratories, and 44% from public healthcare sector
laboratories. Of CRC incident cases, 54% were males.
Throughout the study period, the annual median inci-
dence was 2292 cases per year (interquartile range
(IQR): 2132–3081). The mean age at diagnosis was 61.7
years (±14.1 standard deviation (SD) years) and 61.8
years (±14.7 SD years) for males and females respect-
ively. The White population group had the highest
percentage of CRC cases (49%) compared to other popu-
lation groups. (Table 1).
There were 26,836 CRC deaths with an annual median
of 2138 (IQR: 1982–2321) between 2002 and 2014. Fe-
males accounted for 53% of all CRC deaths. The mean
age at death was 64 years (±14.9 SD years) and 66 years
(±15.7 SD years) for males and females respectively.
Sixty-three percent of the deaths were among adults
over 60 years of age. The White population group re-
ported the highest proportion of deaths for CRC at 41%,
while the Asian population group reported the lowest
deaths at 4%. The mortality incidence ratio by age group
was highest among the Black population group and low-
est among the White population group (data not
shown).
Age-specific incidence and mortality rates
Figures 1 and 2 illustrate age-specific incidence and
mortality rates for males and females in SA between
2002 and 2014. Rates in males and females increased
proportionally until the age of 50 years, after which the
rate for males was higher than the rate for females for
both incidence and mortality. Rates peaked in the age
group of 75 years and older.
Age-standardised incidence rates trends
On average, for males and females combined, there was
2.5% annual average increase in ASIR from 2002 to 2014
(annual average percentage change (AAPC) = 2.5, 95%
CI: 0.6–4.5, p-value < 0.001) (Table 2). ASIR ranged
from 11.6 to 13.5 and 8.5 to 10.6 / 100,000 population
per year for the study period among males and females,
respectively. Overall the ASIR were higher among males
compared with females (Figs. 3 and 4).
Among males, the highest ASIR was observed among
the White population group at 28.12 per 100,000 popu-
lation in 2014. This rate was 1.3, 1.4, and 8.6 times
higher than Mixed race (19.83/100,000), Asian (21.31/
100,000), and Black (3.26/100,000) population groups,
respectively (Fig. 4). While the CRC ASIR remained
stable among males of the Mixed race and Asian
population groups, the ASIR among males of the Black
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population group increased consistently at 3.4% from
2002 to 2014 (AAPC = 3.4, 95% CI: 1.5–5.3, p-value
< 0.001) (Table 2). Among males of the White
population group, a significant decrease of 8.8% was
observed from 2002 to 2007 (AAPC = − 8.8, 95% CI:
− 14.0- -3.2, p-value < 0.001) followed by a 10.4%
increase from 2007 to 2014 (AAPC = 10.4, 95%CI:
6.6–14.4, p-value < 0.001) (Table 2).
As shown in Fig. 5, the highest ASIR among females
were observed in the year 2014 at 18.5 per 100,000
population for the White population group. The ASIR in
2014 were similar for Asian and Mixed race population
groups at (10.6/100,000) and (10.6/100,000) respectively.
In the same year, Black females reported the lowest
ASIR at 2.3 per 100,000 population. The ASIR among fe-
males of the Mixed race and Asian population group
remained stable, while the ASIR among females of the
Black population group increased consistently at 4.3%
from 2002 to 2014 (AAPC = 4.3, 95% CI: 1.9–6.7, p-value
< 0.001). Among females of the White population group,
the ASIR trend remained stable until 2009, when ASIR
increased by 14.9% from 2009 to 2014 (AAPC = 14.9,
95% CI: 6.4–24.2, p-value < 0.01) (Table 2).
Age-standardised mortality rates trends
On average, for males and females combined, the ASMR
increased by 1.3% from 2002 to 2014 (AAPC = 1.3, 95%
CI: 0.1–2.6, p-value < 0.01) (Table 2). The overall ASMR
ranged from 7.1 to 8.9 and 5.5 to 5.9 /100,000 popula-
tion per year for the study period among males and fe-
males, respectively. Similar to ASIR, the overall ASMR
was higher in males than females (Figs. 5 and 6).
The highest ASMR in males was observed in the
White population group in 2004 at 15.1 per 100,000
population, and this rate was 1.2, 1.7 and 6.0 times
higher than the Asian (12.2/100,000), Mixed race (8.6/
100,000), and Black (2.5/100,000) population groups in
2004, respectively (Fig. 5). For males, over the study
Table 1 Characteristics of Colorectal cancer cases and deaths
(2002–2014) in SA
Colorectal cancer
cases, (N = 33,232)
N(%)
Colorectal cancer
death, (N = 26,836)
N(%)
Age
Mean (SD) 61.70(±14.38) 65.19 (±14.91)
Age group (years)
< 15 24 (0.1%) 20 (0.1%)
15–30 894 (2.7%) 551 (2.1%)
31–45 3578 (10.8%) 2272 (8.5%)
46–60 9817 (29.5%) 6447 (24.0%)
> 60 17,760 (53.4%) 16,915 (63.0%)
Missing 1159 (3.5%) 631 (2.4%)
Sex
Female 15,208 (45.8%) 14,109 (52.6%)
Male 17,995 (54.1%) 12,702 (47.3%)
Missing 29(0.1%) 25 (0.1%)
Population group
Black 8942 (26.9%) 7163 (26.7%)
Mixed race 4613 (13.9%) 2645 (9.9%)
Asian 1878 (5.7%) 1169 (4.4%)
White 16,207 (48.8%) 10,919 (40.7%)
Missing 1592 (4.8%) 4940 (18.4%)
Laboratory type
Private 18,666 (56.2%) –
Public 14,566 (43.8%) –
Marital status
Divorced – 4412 (16.4%)
Married – 10,630 (39.6%)
Never_Married – 4887 (18.2%)
Widowed – 2648 (9.9%)
Missing – 4259 (15.9%)
Fig. 1 Average age-specific incidence rates, 2002–2014 in SA
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period, the ASMR remained stable among the White
and Asian population groups and increased consistently
among the Mixed race and Black population groups by
3.0% (AAPC = 3.0, 95% CI: 0.4–5.7, p-value < 0.01) and
4.2% (AAPC = 4.2, 95% CI: 2.0–6.5, p-value < 0.01) from
2002 to 2014, respectively (Table 2).
Among females the highest ASMR was reported
among the White population group at 10.3 per 100,000
population in 2004, this rate was 1.4, 1.5 and 6.3 times
higher than the Asian (7.3/100,000), Mixed race (6.8/
100,000) and the Black (1.6/100,000) population groups,
respectively (Fig. 6). Among females, a significant change
in ASMR was only observed among the Black population
group, where the ASMR increased by 3.4% from 2002 to
2014 (AAPC = 3.4, 95% CI: 2.0–4.8, p-value < 0.01)
(Table 2). The ASMR of females among other popula-
tion groups remained stable (Table 2).
Discussion
This is the first study in SA to assess national CRC inci-
dence and mortality trends by population group and sex.
We reported overall ASIR from 11.6 to 13.5 and 8.5 to
10.6 per 100,000 population per year for the study
period among males and females, respectively. The over-
all ASMR ranged from 7.1 to 8.9 and 5.5 to 5.9 per100,
000 population per year for the study period among
males and females respectively. The ASIR and ASMR
were highest amongst the White population group and
lowest amongst the Black population group. However,
the Black population group demonstrated a consistent
increase in both ASIR and ASMR for the study period.
The age at diagnosis was much closer to the age at death
with the average age at diagnosis being 61 years and the
average age at death being 65 years. These findings sug-
gest that most cases are diagnosed at a late stage and
Fig. 2 Average age-specific mortality rates, 2002–2014 in SA




Sex Age-standardised Incidence Age-standardised Mortality
Period AAPC (95%CI) Period AAPC (95%CI)
Asian Males 2002–2014 0.6 (−2.0,3.2) 2002–2014 2.4(−0.4, 5.4)
Females 2002–2014 3.7 (− 0.2, 7.7) 2002–2014 −0.3(− 2.8, 2.3)
Mixed race Males 2002–2014 1.2 (−0.8,3.3) 2002–2014 3.0*(0.4,5.7)
Females 2002–2014 2.5 (−0.0,5.2) 2002–2014 1.3(−0.5, 3.1)
White Males 2002–2007 −8.8*(− 14.0,-3.2) 2002–2014 0.5(−0.6,1.6)
Males 2007–2014 10.4*(6.6,14.4) – –
Females 2002–2009 − 3.7 (−8.0, 0.9) 2002–2014 −0.2(−1.3,1.0)
Females 2009–2014 14.9*(6.4,24.2) – –
Black Males 2002–2014 3.4*(1.5,5.3) 2002–2014 4.2*(2.0,6.5)
Female 2002–2014 4.3*(1.9,6.7) 2002–2014 3.4*(2.0,4.8)
All All 2002–2014 2.5*(0.6,4.5) 2002–2014 1.3*(0.1,2.6)
*The average annual percentage change (AAPC) is statistically significant: p-value < 0.05
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hence mortality occurs soon after diagnosis and further
studies are warranted to delineate this relationship.
Screening and early detection of colorectal cancer are
recommended as the survival rate is highly dependent
on the stage at diagnosis. The age at diagnosis is com-
parable with other sub-Saharan African countries and
the United State of America where most of the cases are
diagnosed between the ages of 65 and 68 years [27].
The incidence and mortality were higher in males
compared to females. Our study found that there was no
significant difference in the pattern of CRC age-specific
incidence and mortality rates between males and fe-
males. The association between sex and CRC is not fully
understood. The disparities found in other studies are
partly attributed to differences in exposures and risk fac-
tors across sex, such as smoking behaviour and
hormones [28–30]. Further studies are needed to under-
stand the relationship between CRC and sex to imple-
ment possible interventions to reduce CRC incidence in
South Africa.
We found that between 2002 and 2014, the overall
ASIR and ASMR increased by 2.5 and 1.3% respectively.
As expected for countries undergoing rapid developmen-
tal transition and are considered to be medium-to-high
HDI, the overall incidence and mortality rates of CRC in
SA are increasing with increasing HDI [10, 31–33]. The
increase in ASIR is linked to changes in individual be-
haviour, in particular, lifestyle changes influenced by
Fig. 3 CRC age-standardised incidence rates among males, 2002–2014 in SA
Fig. 4 CRC age-standardised incidence rates among females, 2002–2014 in SA
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westernisation [34]. These lifestyle factors include exces-
sive tobacco smoking, excessive alcohol consumption,
lack of physical activity leading to obesity, and poor diet
i.e. consumption of fast food and red meat, among other
factors [35–39]. The increase in ASMR might be associ-
ated with quality of care within the country’s health sys-
tem, for example, inefficient resource allocation (human
resources, equipment and medical supplies), lack of ac-
cess to cancer treatment and or management, and poor
health infrastructure may affect mortality rates [7, 35,
40–45]. Other factors include low or lack of awareness,
and screening and early detection to detect and remove
precancerous polyps as early as possible before they pro-
gress into cancerous lesions, as well as late diagnosis,
translating into poor prognosis and ultimately increased
mortality rates [46–49].
The ASIR and ASMR trends differed across population
groups. In 2014, the White population group had the
highest ASIR and ASMR, followed by the Asian
population group, Mixed race population group, and
then the Black population group. The most significant
and highest trend changes over time were observed
among the Black population group. This is of particular
concern as the Black population group comprises 87% of
the total SA population [50]. Traditionally, large dispar-
ities in access to healthcare exist among the different
population groups in SA. For example, the majority of
the White population in SA have access to adequate
healthcare services in the private healthcare sector,
which has more resources [50, 51]. According to the
STATS SA general household survey in 2017, 75% of the
White population group have private health insurance
compared to 10% of the Black population group [52]. In-
creasing cancer trends and poor access to healthcare ser-
vices combined could exacerbate the cancer disparity in
SA. The disparities noted were also observed in a study
conducted in the United States, where the proportions
of CRC incidence were 59% for Whites and 30% for
Fig. 5 CRC age-standardised mortality rates among males, 2002–2014 in SA
Fig. 6 CRC age-standardised mortality rate among females, 2002–2014 in SA
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Blacks. However, the Annual Percentage Change (APC)
for Blacks was 1.6 times higher than Whites [53]. The
cause of variation of patterns and rates across population
groups and sex may be attributed to socioeconomic dis-
parities and differential risk behaviours [54, 55].
Stable ASIR and ASMR were observed among the
Asian population group and females of the Mixed race
population group over the study period. Stable ASIR but
increasing ASMR was observed among Mixed race
males. The Asian and Mixed race population groups ac-
count for 11% of the total population; thus, the numbers
are likely too low to show a significant change in relation
to other population groups [50, 56, 57]. However, the
level of access to healthcare services among individuals
of the Asian and Mixed race population groups
remained fairly similar 4 and 10 years post-democracy
(1994), a possible explanation for the rate of CRC diag-
nosis remaining stable [57, 58].
Among the White population group, the ASIR de-
creased from 2002 to 2007 for males and remained
stable for females from 2002 to 2009, and then later in-
creased from 2007 to 2014 for males, and from 2000 to
2014 for females. The ASMR remained stable through-
out the study period for both males and females. The
stabilisation or reduction observed between 2002 to
2009 may be partly attributed to the effects of withhold-
ing cancer reporting to NCR by private sector laborator-
ies between 2005 and 2010 before the promulgation of
Regulation 380 of the National Health Act no 61 of 2003
[59, 60]. An estimated 16% of the SA population seeks
care in the private health sector, of which 92% are
Whites, and hence the ASIR trends mimic the reporting
levels during and few years after the data withholding
period [60]. The stable ASMR was expected among the
White population group, as 88% of the White population
group have access to adequate healthcare services pro-
vided by the private healthcare sector [52]. The screen-
ing rates are higher than other population groups, which
translates into early detection and treatment, and ultim-
ately better prognosis and lower death rates, hence the
stable mortality pattern observed [61, 62].
A consistent increase in ASIR and ASMR was ob-
served among the Black population group throughout
the study period. This may be explained by the rapid
transition of the Black population group’s socioeconomic
status and change in lifestyle [63, 64]. The increased
adoption of western lifestyles and consequently, dietary
changes as well as other risk factors for CRC may have
led to an increase in CRC incidence among Black South
Africans. This phenomenon is also observed by other
African countries experiencing rapid westernisation [64,
65]. Secondly, the incidence pattern may be attributed to
an increase in cancer reporting for the Black population
group, which constitutes > 80% of the total SA
population that was excluded from accessing quality
healthcare services pre-democracy [49, 57, 66]. The ASMR
trends observed may be explained by inequities in socio-
economic status differences. There is a general lack of ac-
cess to quality healthcare services, late diagnosis of cancer,
and limited treatment options available for poorer South
Africans, as only 8% the Black population group can afford
private medical insurance in SA [52, 67].
Limitations
This study had several limitations. The incidence data
used in this study was derived from the NCR. The NCR
is a passive pathology-based cancer registry that collects
histological, haematologically, and cytologically diag-
nosed cancer cases; therefore, CRC cases not diagnosed
through laboratory means are excluded [18]. Between
2005 and 2007, cancer case reporting and data collection
from private health facilities were limited due to con-
cerns around confidentiality and the lack of legislature
support on cancer reporting/surveillance in SA [60].
This may cause an underreporting of CRC incidence dis-
proportionately amongst certain population groups that
predominately utilised private healthcare facilities such
as the non-Black population groups [60]. The lack of
cancer staging in both the NCR and STATS SA data
makes it more challenging to explore disparities in can-
cer incidence and mortality across population groups.
The data for cancer mortality was derived from STATS
SA. Underreporting of death was likely across all popula-
tion groups. In 2007, the completeness of mid-year esti-
mates and vital statistics was below 90% as found by an
evaluation [68]. This underreporting occurs because of de-
layed reporting, ill-defined causes of death, and misreport-
ing or misclassification of cause of death [69].
Despite these limitations, this is the first national study
to report CRC ASIR and ASMR trends in SA. Improve-
ments in the accuracy of reporting will occur with more
triangulation of data sources. Secondly, the data sources
used are the primary source of cancer statistics in SA.
This study has reported the CRC ASIR and ASMR,
which were comparable with other rates reported by
previous regional and international studies [70, 71].
Conclusion
The increase in CRC ASIR and ASMR is an indication
of the epidemiological transition of disease burden in SA
with increasing HDI. The disparities across population
groups, in particular, the consistent and rapid increase
in ASIR among the Black population group, requires fur-
ther in-depth studies to delineate the factors driving the
increasing rates. Programs for promoting healthier be-
haviours such as reducing alcohol intake, reducing to-
bacco smoking, and increasing physical activities are
recommended to reduce the risk of CRC in SA. The
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inequalities can be bridged through universal health
coverage, targeted screening, early detection, and high-
quality cancer care provision, especially for previously
disadvantaged population groups. Enhancement of can-
cer surveillance, in particular, population-based cancer
registration is required to produce better quality cancer
data for in-depth exploratory research to better inform
policies and interventions for cancer prevention and
control in SA.
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